Drug Database
AD

adenovirus vaccines

✓ Approved

Teva Pharmaceutical Industries Ltd. · 疫苗 · 疫苗

什么是 adenovirus vaccines?

adenovirus vaccines 是一种疫苗,由Teva Pharmaceutical Industries Ltd.研发。该药已获批,用于治疗相关适应症,给药途径:Oral (PO)。

药物档案

公司Teva Pharmaceutical Industries Ltd.
药物类别疫苗, 大分子
给药途径Oral (PO)
状态Approved

治疗适应症

adenovirus vaccines 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Infections and infestationsAdenovirus infection✓ Approved

相关研究文献

PubMedNPJ vaccines2026-11-19

Efficacy, safety, and biodistribution of intranasally delivered adenoviral COVID-19 vaccine in hamsters.

Laham-Karam N N, Mäkinen P P, Koivulehto E E, Gurzeler E E et al.

Coronavirus disease 2019 (COVID-19) continues to cause outbreaks around the world despite the vast COVID-19 vaccination programs. Thus, it is important to continue developing better vaccines to protect vulnerable populations. Here, we studied the efficacy, safety, persistence and biodistribution of an adenovirus-based COVID-19 vaccine delivered intranasally. Our results confirmed that mucosal delivery leads to effective protection against infection in hamsters. A comparative study of different adenoviral vectors demonstrated that specifically Ad5-S-3M, expressing the SARS-CoV-2 spike glycoprotein ectodomain with inclusion of three common receptor binding domain mutations, induced a robust humoral immune response and effectively protected hamsters from SARS-CoV-2 infection. In addition, longitudinal analysis of vaccinated hamsters' tissues demonstrated durable vaccine transgene expression and persistent vector DNA in the nasal turbinates. This persistence may be beneficial in increasing the duration of immunity. Expression of the S-3M did not cause any aberrant changes in the hamster tissues and resulted in very few changes in cellular mRNA expression in target tissues. Safety and biodistribution assessment demonstrated restricted non-target tissue distribution of intranasally delivered vector and no significant changes in clinical blood chemistry, underlining the safety of the vaccine. These results further support that intranasal delivery is a promising approach for mucosal vaccine administration against respiratory infection pathogens and extend our knowledge of Adeno-vector persistence.

PMID 43052363
阅读全文 →
PubMedNPJ vaccines2026-11-19

Thrombotic and cerebrovascular events following SARS-CoV-2 vaccination: an umbrella review of systematic reviews and meta-analyses.

Aderinto Nicholas N, Hasan Ahmedyar A, Abioye Aderinola Halimat AH, Mbah Ebube Christopher EC et al.

Rare thrombotic and cerebrovascular events have been reported after SARS-CoV-2 vaccination, raising safety concerns. This umbrella review synthesizes evidence from 19 systematic reviews and meta-analyses examining thrombotic outcomes, including acute ischemic stroke and cerebral venous sinus thrombosis, across different vaccine platforms. Methodological quality was assessed using AMSTAR-2, and findings were synthesized by outcome and platform. Evidence consistently shows that thrombotic and cerebrovascular events following vaccination are rare. mRNA vaccines (BNT162b2, mRNA-1273) were not associated with increased risk beyond background population rates. Adenoviral vector vaccines (ChAdOx1 nCoV-19, Ad26.COV2.S) were linked to a rare syndrome of vaccine-induced immune thrombotic thrombocytopenia, most commonly presenting as cerebral venous sinus thrombosis in younger adults. Evidence for whole-virus vaccines was limited but did not indicate consistent safety concerns. Across all platforms, thrombotic risk was substantially lower than that from SARS-CoV-2 infection. Overall, vaccination benefits outweigh risks, highlighting the importance of ongoing surveillance and transparent communication.

PMID 43052353
阅读全文 →
PubMedBiotechnology letters2026-11-19

Screening of high-strength subgenomic promoters of alphavirus replicase and their co-expression potential in saRNA vaccines.

Zhai Lixin L, Li Liang L, Liu Lei L, Yu Xingao X et al.

Self-amplifying mRNA (saRNA) vaccines represent a promising platform for next-generation vaccines. However, their application is still limited by insufficient antigen expression and the difficulty of achieving precise multi-gene regulation in multivalent vaccine designs. Subgenomic promoters (SGPs) derived from Alphavirus replicase play a critical role in regulating downstream gene transcription and therefore provide an attractive target for promoter engineering. In this study, the 24 nt core sequence of the Alphavirus SGP was targeted for optimization. A randomized mutation library was constructed and screened using a high-throughput fluorescence detection system based on enhanced green fluorescent protein (EGFP) as a reporter. Candidate promoters were subsequently validated through sequencing analysis and cellular expression assays. A total of 20 novel SGP variants with enhanced transcriptional activity were successfully identified. Among them, the 9 G → T mutant showed the most prominent improvement in expression performance. Semi-quantitative fluorescence analysis confirmed that several mutant promoters significantly accelerated the onset of target protein expression and increased overall expression levels compared with the wild-type promoter. RNA secondary structure prediction further suggested that the enhanced promoter activity may be associated with alterations in local stem-loop conformations within the SGP region. In addition, co-transfection assays further demonstrated that the 9 G → T mutant maintains favorable co-expression compatibility with the wild-type SGP, indicating its potential utility in multigene expression systems. These findings provide a set of high-strength subgenomic promoters and an effective screening strategy for saRNA systems, offering practical regulatory elements for improving antigen expression and facilitating the development of multivalent saRNA vaccines.

PMID 43052572
阅读全文 →
PubMedHistology and histopathology2026-11-19

Upregulation of USP48 expression in gastric biopsies is indicative of gastric adenocarcinoma.

Ferino Lorena L, Täger Christian C, Schnizler Stephan S, Vieth Michael M et al.

Gastric diseases, such as gastritis, gastric ulcers, or gastric cancer, are common worldwide with increasing prevalence over the past decades, and chronic infections with Helicobacter pylori or Epstein-Barr virus could increase the risk of gastric cancer. Molecular dysregulation of deubiquitinylases (DUBs) in immune responses, DNA repair, or cell cycle control affect the development of a variety of diseases. Ubiquitin-specific peptidase 48 (USP48) is a DUB in the USP family, the largest group of DUBs in humans, and might serve as a new prognostic marker for gastric diseases. Upon H. pylori infection, USP48 affects the inflammatory immune response by controlling the transcription factor nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB). In our study, we show that USP48 is localized in the nucleus of primary monolayer mucosoids derived from 3D gastric organoids made from non-pathological tissue. Furthermore, using gastric biopsies from 326 patients, we examined USP48 expression levels in the cell nucleus in the course of gastric pathology. We observed that the nuclear expression level of USP48 was not altered in autoimmune (A-type) gastritis (p=0.9021) or in chemically induced C-type gastritis (p=0.83). However, tissue from Type-B H. pylori-caused gastritis showed USP48 upregulation, albeit without statistical significance (p=0.0616). In contrast, eradication of the pathogen (Ex-HP-gastritis) caused a significant decrease in USP48 expression (p=0.0021). Further, we observed no significant difference in USP48 expression in adenomas (p=0.416) or diffuse adenocarcinomas (p=0.3593), while USP48 expression was significantly upregulated in intestinal adenocarcinomas (p=0.0005).

PMID 43053758
阅读全文 →
PubMedNPJ vaccines2026-11-19

Chitosan-based nanoparticles encapsulating Nocardia seriolae lysates confer protection against nocardiasis through immersion vaccination in Micropterus salmoides.

Li Lijuan L, Liu Zhimin Z, Sun Yihan Y, Li Kesong K et al.

Development of effective vaccines with convenient administration, including oral immunization or immersion, to control pathogens is important for the sustainability of aquaculture. Nocardia seriolae was found to harm over 40 types of cultured marine and freshwater species, especially in Micropterus salmoides and Channa argus, causing more than 30% mortality. In this study, a novel isolate of N. seriolae (B20200724) growing fast and manifesting comparative virulence with other N. seriolae was identified from diseased M. salmoides. Chitosan-based nanoparticles encapsulating whole-cell lysates of N. seriolae B20200724 with great mucoadhesive features were prepared for evaluation of the protective effect against N. seriolae in M. salmoides. Chitosan-based nanoparticles via immersion vaccination boost the innate immune response, elicit the expression of Th2 cytokines and high-titer antibody responses, ultimately conferring a 45% relative protection rate against N. seriolae infection. These findings provide a novel vaccine candidate and verify a convenient immunization route, which promotes the potential of the vaccine against fish nocardiosis for commercial use.

PMID 43052343
阅读全文 →
PubMedMethods in molecular biology (Clifton, N.J.)2026-11-19

Prediction of Human-Virus Protein-Protein Interactions.

Ye Xiao X, Li Yixue Y, Huang Tao T

Human-Virus Protein-Protein Interactions (HV-PPIs) are the core mechanisms underlying viral invasion of host cells, completion of the viral life cycle, and induction of pathological responses. Predicting HV-PPIs in higher accuracy is of great significance for elucidating viral pathogenic mechanisms, developing antiviral drugs, and designing vaccines. However, traditional experimental methods such as Yeast Two-Hybrid (Y2H) and Affinity Purification-Mass Spectrometry (AP-MS) face bottlenecks including low throughput, high cost, high false positive rates, and incomplete data in the identification of cross-species interactions. In recent years, computational biology approaches, especially deep learning-based multimodal fusion frameworks, have emerged as the primary driving force for accelerating HV-PPIs prediction. This review systematically summarizes the latest advances in the field of HV-PPIs prediction, elaborates on key aspects such as data construction, feature engineering, deep learning architectures, and performance evaluation, summarizes the technical essentials, advantages, and limitations of existing methods, discusses the development trends of the field by integrating representative research findings from recent years, and serves as a reference for future investigations in this domain.

PMID 43052660
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多adenovirus vaccines